Clinical Trial Update: Tislelizumab Combined APF Chemotherapy in the Treatment of Locally Advanced Head and Neck Tumors [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial is investigating tislelizumab in combination with APF chemotherapy (doxorubicin, cisplatin, and 5-fluorouracil) for locally advanced he…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Cancer

Drugs mentioned

• 5-Fluorouracil (5-FU)
• CISPLATIN (cisplatin)
• Doxorubicin (doxorubicin)
• Tislelizumab (tislelizumab)

Snippet

Sponsor: The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School | Conditions: Head and Neck Tumors | Phase 2 | Status: RECRUITING